Carter Bankshares Empowers Gentell's Global Expansion with ManukaMed Acquisition
- Gentell acquires ManukaMed to enhance its honey-based wound care product offerings, now covered by Medicare in the U.S.
- The acquisition supports Gentell's growth strategy and strengthens its presence in the U.S. and international markets.
- Gentell expands operational base with ManukaMed's U.S. headquarters and distribution center, reinforcing its leadership in wound care.
Gentell Expands Global Reach with Acquisition of ManukaMed
In a significant strategic move, Gentell, the leading vertically integrated wound care company, announces its acquisition of ManukaMed, a prominent New Zealand-based manufacturer of honey-based wound dressings. This acquisition positions Gentell to enhance its product offerings by incorporating the only honey-based wound care product currently covered by Medicare and other insurance providers in the United States. The unique medical-grade honey utilized by ManukaMed is scientifically recognized for its efficacy in accelerating the healing of chronic wounds, including venous and pressure ulcers, thereby broadening Gentell’s portfolio in a critical healthcare segment.
David Navazio, President and CEO of Gentell, highlights that the acquisition represents a pivotal moment in the company’s growth trajectory. After three decades of development, starting from a garage operation, Gentell now operates manufacturing facilities in seven countries, including major markets such as the U.S., Canada, and the U.K. The move to rebrand ManukaMed as Gentell ManukaMed allows the company to consolidate its resources and leverage its existing distribution networks, particularly in the U.S. where the demand for innovative wound care solutions is on the rise.
The acquisition also aligns with Gentell's broader expansion strategy, which has included previous acquisitions and new product launches aimed at supporting wound healing. With the recent addition of ManukaMed, Gentell is not only enhancing its presence in the U.S. market but is also poised to grow its footprint in regions such as Australia and Southeast Asia. This expansion reflects Gentell’s commitment to improving patient outcomes through advanced wound care solutions and demonstrates the company’s intention to lead in the global wound care landscape.
In addition to the acquisition, Gentell's operational base expands with the takeover of ManukaMed's U.S. headquarters in Franklin, Tennessee, and its distribution center in Kansas City, Missouri. The company’s recent activities underscore its dedication to innovation and quality in wound care, reinforcing its position as a global leader.
This year has been marked by significant achievements for Gentell, including the establishment of offices in India and the launch of the ReStorell Liquid Protein Supplement line. These initiatives illustrate Gentell's commitment to enhancing wound care solutions worldwide, ensuring that it remains at the forefront of advancements in the healthcare industry.
